Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the interest coverage ratio high or low?
The interest coverage ratio of -8.50x is 98% above its 5-year average of -426.88x, near the high end of its 5-year range (-2477.75x–-4.69x).
20.34% below its 12-month average of -7.06x.
Reported quarterly interest coverage; no daily interpolation. Q2 FY2026 (2026-06-30): -4.69x.
INTEREST COVERAGE RATIO
-8.50x
INTEREST COVERAGE RATIO AVG TTM
-7.06x
INTEREST COVERAGE RATIO AVG 3Y
-8.91x
INTEREST COVERAGE RATIO AVG 5Y
-426.88x
INTEREST COVERAGE RATIO AVG 10Y
N/A
INTEREST COVERAGE RATIO AVG 15Y
N/A
INTEREST COVERAGE RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-20.34%
CURRENT VS 3Y AVG
+4.56%
CURRENT VS 5Y AVG
+98.01%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-6.38x
median of 528 covered companies
CURRENT VS SECTOR MEDIAN
-33.33%
vs the sector median at left
Avita Medical Inc.
Market Cap
$322.71M
Interest Coverage Ratio
-8.50x
TTM Avg
-7.06x
3Y Avg
-8.91x
5Y Avg
-426.88x
Market Cap
$321.76M
Interest Coverage Ratio
1.35x
TTM Avg
1.35x
3Y Avg
1.35x
5Y Avg
1.35x
Market Cap
$318.43M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$329.37M
Interest Coverage Ratio
-85.95x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$330.19M
Interest Coverage Ratio
-10.12x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$311.90M
Interest Coverage Ratio
-0.37x
TTM Avg
0.39x
3Y Avg
0.39x
5Y Avg
0.39x
Market Cap
$309.19M
Interest Coverage Ratio
N/A
TTM Avg
12.71x
3Y Avg
12.71x
5Y Avg
12.71x
Market Cap
$344.04M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | INTEREST COVERAGE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Avita Medical Inc. (RCEL) | $322.71M | -8.50x | -7.06x | -8.91x | -426.88x |
| Sanara MedTech Inc. (SMTI)vs › | $321.76M | 1.35x | 1.35x | 1.35x | 1.35x |
| CapsoVision, Inc. (CV)vs › | $324.76M | N/A | N/A | N/A | N/A |
| C4 Therapeutics, Inc. (CCCC)vs › | $318.43M | N/A | N/A | N/A | N/A |
| Cabaletta Bio, Inc. (CABA)vs › | $329.37M | -85.95x | N/A | N/A | N/A |
| ClearPoint Neuro, Inc. (CLPT)vs › | $330.19M | -10.12x | N/A | N/A | N/A |
| Agenus Inc. (AGEN)vs › | $311.90M | -0.37x | 0.39x | 0.39x | 0.39x |
| Benitec Biopharma Inc. (BNTC)vs › | $309.19M | N/A | 12.71x | 12.71x | 12.71x |
| Relmada Therapeutics, Inc. (RLMD)vs › | $344.04M | N/A | N/A | N/A | N/A |
| Orchestra BioMed Holdings, Inc. (OBIO)vs › | $349.70M | -45.13x | N/A | N/A | N/A |
Interest Coverage
-8.5x
Debt/Equity
N/A
Current Ratio
0.41
Formula: Interest Coverage = EBIT / Interest Expense
Reference ranges:
Note: Interest coverage should be compared with historical interest expense, operating income, and industry capital structure.
Interest Coverage = EBIT / Interest Expense
The interest coverage ratio measures operating earnings relative to interest expense.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | INTEREST COVERAGE RATIO |
|---|---|
| 2026-06-30 | -4.69x |
| 2026-03-31 | -6.18x |
| 2025-12-31 | -8.33x |
| 2025-09-30 | -7.22x |
| 2025-06-30 | -8.90x |
| 2025-03-31 | -9.59x |
| 2024-12-31 | -7.67x |
| 2024-09-30 | -10.16x |
| 2024-06-30 | -11.60x |
| 2024-03-31 | -12.69x |
| 2023-12-31 | -10.94x |
| 2023-09-30 | -930.60x |
| 2023-06-30 | -1595.00x |
| 2023-03-31 | -2477.75x |
| 2022-12-31 | -984.67x |
| 2022-09-30 | -958.00x |
| 2022-06-30 | -1590.50x |
| 2021-12-31 | -770.36x |
| 2021-09-30 | -661.00x |
| 2021-06-30 | -522.67x |
| 2021-03-31 | -1997.00x |
| 2020-12-31 | -1877.00x |
| 2020-09-30 | -1459.14x |
| 2020-06-30 | -1627.88x |
| 2019-06-30 | -283.47x |
| 2019-03-31 | -283.48x |
| 2018-06-30 | -303.89x |
